216
Views
8
CrossRef citations to date
0
Altmetric
Review Article

FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway

&
Pages 493-500 | Received 26 Apr 2020, Accepted 16 May 2020, Published online: 04 Jun 2020

References

  • Wysoczynski M, Guo Y, Moore JT, et al. Myocardial reparative properties of cardiac mesenchymal cells isolated on the basis of adherence. J Am College Cardiol. 2017;69:1824–1838.
  • Lefort C, Benoist L, Chadet S, et al. Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injury. J Mol Cell Cardiol. 2018; 121:212–222.
  • Guo X, Yan F, Shan X, et al. SIRT3 inhibits Ang II-induced transdifferentiation of cardiac fibroblasts through β-catenin/PPAR-γ signaling. Life Sci. 2017;186:111–117.
  • Shimosawa T. Salt, the renin-angiotensin-aldosterone system and resistant hypertension. Hypertens Res. 2013;36:657–660.
  • Sabbadini G, Di Lenarda A, Metra M, et al. Pharmacological therapy of chronic heart failure in the elderly. Ital Heart J. 2004; 5 :37S–51S.
  • Kalinichenko VV, Bhattacharyya D, Zhou Y, et al. Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology. 2003;37:107–117.
  • Hodo Y, Honda M, Tanaka A, et al. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C. Clin Cancer Res. 2013;19:1827–1837.
  • Zhou H, Yu X, Zhou G. NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF β1/Smad3 signaling pathway . Mol Med Rep. 2017;16:3551–3556.
  • Zhao ZG, Wang DQ, Hu DF, et al. Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome. Onco Targets Ther. 2016; 9:1743–1752.
  • Tao H, Chen ZW, Yang JJ, et al. MicroRNA-29a suppresses cardiac fibroblasts proliferation via targeting VEGF-A/MAPK signal pathway. Int J Biol Macromol. 2016;88:414–423.
  • Xiong Q, Wu S, Wang J, et al. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci. 2017;7:16.
  • Shen Y, Cheng F, Sharma M, et al. Granzyme B deficiency protects against angiotensin II-induced cardiac fibrosis. Am J Pathol. 2016;186:87–100.
  • Chen R, Fan X, Chen G, et al. Irisin attenuates angiotensin II-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS/ TGFβ1/Smad2/3 signaling axis. Chem Biol Interact. 2019;302:11–21.
  • Zhang Y, Huang XR, Wei LH, et al. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling . Mol Ther. 2014;22:974–985.
  • Black M, Milewski D, Le T, et al. FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch in myofibroblasts. Cell Rep. 2018;23:442–458.
  • Nilsson G, Kannius-Janson M. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling. BMC Cancer. 2016; 16:142.
  • Wang S, Xiao Z, Hong Z, et al. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA. Cancer Lett. 2018;439:78–90.
  • Fulford L, Milewski D, Ustiyan V, et al. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Sci Signal. 2016;9:a48.
  • Ina K, Kitamura H, Tatsukawa S, et al. Significance of α-SMA in myofibroblasts emerging in renal tubulointerstitial fibrosis. Histol Histopathol. 2011;26:855–866.
  • Davis J, Molkentin JD. Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol. 2014;70:9–18.
  • Zhang W, Chang H, Zhang H, et al. MiR-30e attenuates isoproterenol-induced cardiac fibrosis through suppressing Snai1/TGF-β signaling . J Cardiovasc Pharmacol. 2017;70:362–368.
  • Lijnen PJ, van Pelt JF, Fagard RH. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther. 2012;30:e1–e8.
  • Liu M, Yeh J, Huang Y, et al. Effect of triptolide on proliferation and apoptosis of angiotensin II-induced cardiac fibroblasts in vitro: a preliminary study. AJTCAM. 2016;14:145–154.
  • Su Q, Zhang Y. Glaucocalyxin A attenuates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts. Biochem Biophys Res Commun. 2018;503:1949–1954.
  • Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004;63:423–432.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.